Glenmark Pharmaceuticals
GLENMARK.NS
#2750
Rank
โ‚น418.35 B
Marketcap
โ‚น1,483
Share price
1.10%
Change (1 day)
90.65%
Change (1 year)

Revenue for Glenmark Pharmaceuticals (GLENMARK.NS)

Revenue in 2024 (TTM): โ‚น118.60 Billion

According to Glenmark Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚น120.28 Billion. In 2023 the company made a revenue of โ‚น119.20 Billion an increase over the revenue in the year 2022 that were of โ‚น117.26 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Glenmark Pharmaceuticals from 2012 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น118.60 B-0.5%
2023 โ‚น119.20 B1.65%
2022 โ‚น117.26 B-2.63%
2021 โ‚น120.42 B12.68%
2020 โ‚น106.87 B4.66%
2019 โ‚น102.12 B8.33%
2018 โ‚น94.26 B3.04%
2017 โ‚น91.48 B4.62%
2016 โ‚น87.45 B24.85%
2015 โ‚น70.04 B8.38%
2014 โ‚น64.62 B14.64%
2013 โ‚น56.37 B18.87%
2012 โ‚น47.42 B